Tracheoscopy
Conditions
Interventions
Sevoflurane group:Intranasal saline
Intranasal dexmedetomidine 0.5 ug/kg group:Intranasal dexmedetomidine 0.5 ug/kg
Intranasal dexmedetomidine 1.0 ug/kg group:Intranasal dexmedetomidine 1.0 ug/kg
Intranasal dexmedetomidine 1.5 ug/kg group:Intranasal dexmedetomidine 1.5 ug/kg
Intranasal dexmedetomidine 2.0 ug/kg group:Intranasal dexmedetomidine 2.0 ug/kg group
Sponsors
Yuxi Children`s Hospital
Eligibility
Sex/Gender
All
Age
1 Years to 15 Years
Inclusion criteria
Inclusion criteria: 1 ASA Level 1-3 2 Ages 1-15 3 Children undergoing tracheoscopy under sevolfurane
Exclusion criteria
Exclusion criteria: 1 Family members declined to participate in the study 2 Children with cyanotic congenital heart disease 3 Children with abnormal neurological or psychiatric development 4 weeks of gestation + preterm infants aged less than 42 weeks after birth 5 Children whose condition requires fasting 6 Children with known hepatic and renal impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emergence agitation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative vital signs;Sedation scale;Side effects; | — |
Countries
China
Contacts
Public ContactGuo Hongsong
Yuxi Children`s Hospital
Outcome results
None listed